Skip to main navigation Skip to main content Skip to page footer

Infections transmises par les tiques

Informations cliniques

Les tiques peuvent transmettre divers agents infectieux viraux, bactériens et parasitaires à l’homme lorsqu’elles se nourrissent de sang. Outre Borrelia, responsable de la borréliose de Lyme, la maladie transmise par les tiques la plus fréquente dans l’hémisphère nord, l’éventail des agents pathogènes comprend le virus de l’encéphalite à tiques, le virus de la fièvre de Crimée-Congo, Anaplasma, Rickettsia, Babesia, Ehrlichia et Coxiella. Les infections transmises par les tiques peuvent, en fonction de l’agent pathogène, entraîner une multitude de symptômes cliniques, notamment au niveau de la peau, des articulations, des muscles, des organes internes et du système nerveux central. Des infections asymptomatiques ou subcliniques sont possibles, tout comme des évolutions graves mettant la vie en danger. Comme il n’existe que des vaccins pour certains des agents pathogènes transmis par les tiques, la prophylaxie de l’exposition est la protection la plus efficace.

Diagnostic

Le diagnostic de laboratoire des infections transmises par les tiques repose sur des méthodes de détection directes et indirectes. Les méthodes directes comprennent par exemple les étalements sanguins, les cultures d’agents pathogènes ou les tests basés sur la PCR, tandis que la détection indirecte repose généralement sur la détermination d’anticorps spécifiques dirigés contre l’agent infectieux concerné dans le sérum, le plasma ou le liquide céphalorachidien du patient. Dans les cas où il est difficile d’obtenir un échantillon approprié pour la détection directe de l’agent pathogène ou lorsque la quantité d’agent pathogène qu’il contient est trop faible, la détection des anticorps constitue souvent la principale méthode de diagnostic de laboratoire. EUROIMMUN propose une large gamme de systèmes de tests sérologiques, notamment des ELISA, des ChLIA, des tests d’immunofluorescence (IFI), des immunoblots et des EUROMicroblots, des immunoblots miniaturisés en format microplaque.

Methods
Technology Parameter Substrate Species Calibration Ig Class Format Order No.
ELISA Anti-TBE Virus CSF ELISA 2.0 (IgG)
tick-borne encephalitis virus
antigen-coated
microplate wells
TBE viral proteins 5/25/50/100/175/230 U/ml IgG 96 x 01
EI 2661-9601-2L G
ELISA Anti-TBE Virus CSF ELISA 2.0 (IgM)
tick-borne encephalitis virus
antigen-coated
microplate wells
TBE viral proteins IgM 96 x 01
EI 2661-9601-2L M
ELISA CSQ pair of controls
anti-Borrelia (IgG)
IgG 02 x 20
CK 2132-0220-L G
ELISA Anti-Borrelia CSF ELISA 2.0 (IgM) antigen-coated
microplate wells
TBE viral proteins IgM 96 x 01
EI 2132-9601-2L M
ELISA CSF: Anti-Borrelia plus VlsE ELISA (IgG)
Sample type: CSF/serum pair
antigen-coated
microplate wells
whole antigen, detergent extracts of
Borrelia burgdorferi sensu stricto,
Borrelia garinii and Borrelia afzelii
PLUS recombinant VlsE from
Borrelia burgdorferi sensu stricto
5/25/50/100/175/230 U IgG 96 x 01
EI 2132-9601-L G
EUROLINE Anti-Borrelia EUROLINE-RN-AT (IgG)
(p18, p19, p20, p21, p58,
OspC (p25), p39, p83, LBb, LBa,
VlsE Bg, VlsE Bb, VlsE Ba separately)
EUROLINE IgG
IgG
IgG
240 x 01
32 x 01
50 x 01
DN 2131-24001 G
DN 2131-3201 G
DN 2131-5001 G
EUROLINE Anti-Borrelia EUROLINE-RN-AT (IgM)
(OspC Bg native, OspC Bb native,
OspC Ba native, p39, VlsE Bb separately)
EUROLINE IgM
IgM
IgM
240 x 01
32 x 01
50 x 01
DN 2131-24001 M
DN 2131-3201 M
DN 2131-5001 M
ELISA Anti-Crimean-Congo fever virus(CCHFV) ELISA (IgG) antigen-coated
microplate wells
recombinant
protein from CCHFV
2/20/200 RU/ml IgG 96 x 01
EI 279a-9601 G
ELISA Anti-Crimean-Congo fever virus(CCHFV) ELISA (IgM) antigen-coated
microplate wells
recombinant
protein from CCHFV
semi-quantitative IgM 96 x 01
EI 279a-9601 M
IIFT TBE virus (TBEV) infected and non-
infected cells
(2 BIOCHIPs per field)
EU 14 IgG
IgM
IgG
IgM
10 x 05
10 x 05
10 x 10
10 x 10
FI 2661-1005 G
FI 2661-1005 M
FI 2661-1010 G
FI 2661-1010 M
IIFT Flavivirus Mosaic 1
TBE virus (TBEV)
West Nile virus (WNV)
Japanese encephalitis virus (JEV)
Yellow fever virus (YFV)
4 BIOCHIPs per field:
infected cells
infected cells
infected cells
infected cells

EU 14
EU 14
EU 14
EU 14
IgG
IgM
IgG
IgM
10 x 05
10 x 05
10 x 10
10 x 10
FI 2661-1005-1 G
FI 2661-1005-1 M
FI 2661-1010-1 G
FI 2661-1010-1 M
IIFT Flavivirus Profile 2
upper row:
TBE virus (TBEV)
West Nile virus (WNV)
Japanese encephalitis virus (JEV)
Yellow fever virus (YFV)
bottom row:
Dengue virus
types 1 - 4 (DENV)


infected cells
infected cells
infected cells
infected cells

infected cells


EU 14
EU 14
EU 14
EU 14

EU 14
IgG
IgM
IgG
IgM
10 x 05
10 x 05
20 x 05
20 x 05
FI 2661-1005-2 G
FI 2661-1005-2 M
FI 2661-2005-2 G
FI 2661-2005-2 M
ELISA Anti-TBE Virus ELISA 2.0 (IgG)
tick-borne encephalitis virus
antigen-coated
microplate wells
TBE viral proteins IgG 96 x 01
EI 2661-9601-2 G
ELISA Anti-TBE Virus ELISA 2.0 (IgM)
tick-borne encephalitis virus
antigen-coated
microplate wells
semi-quantitative IgM 96 x 01
EI 2661-9601-2 M
IIFT EUROPLUS
Borrelia afzelii
Borrelia burgdorferi (USA)
OspC antigen
VlsE antigen
4 BIOCHIPs per field:
bacterial smear
bacterial smear
OspC BIOCHIPs
VlsE BIOCHIPs

B. afzelii
B. burgd. (USA)
B. burgdorferi
recombinant
IgG
IgM
IgG
IgM
10 x 05
10 x 05
10 x 10
10 x 10
FI 2136-1005-1 G
FI 2136-1005-1 M
FI 2136-1010-1 G
FI 2136-1010-1 M
ELISA Anti-Borrelia ELISA (IgM)
whole antigen extracts of
Borrelia burgdorferi sensu stricto,
Borrelia garinii and Borrelia afzelii
antigen-coated
microplate wells
whole antigen, detergent extracts of
Borrelia burgdorferi sensu stricto,
Borrelia garinii and Borrelia afzelii
2/20/200 RU/ml IgM 96 x 01
EI 2132-9601 M
ELISA Anti-Borrelia plus VlsE ELISA (IgG)
whole antigen extracts of
Borrelia burgdorferi sensu stricto,
Borrelia garinii and Borrelia afzelii
plus recombinant VlsE
antigen-coated
microplate wells
whole antigen, detergent extracts of
Borrelia burgdorferi sensu stricto,
Borrelia garinii and Borrelia afzelii
plus recombinant VlsE from
Borrelia burgdorferi sensu stricto
2/20/200 RU/ml IgG 96 x 01
EI 2132-9601-2 G
ELISA Anti-Coxiella burnetii Phase 1 ELISA (IgG) antigen-coated
microplate wells
native antigens
from Coxiella burnetii cells
in the chronical phase
semi-quantitative IgG 96 x 01
EI 217a-9601-1 G
ELISA Anti-Coxiella burnetii Phase 2 ELISA (IgG) antigen-coated
microplate wells
native antigens
from Coxiella burnetii cells
in the acute phase
semi-quantitative IgG 96 x 01
EI 217a-9601-2 G
ELISA Anti-Coxiella burnetii Phase 2 ELISA (IgM) antigen-coated
microplate wells
native antigens
from Coxiella burnetii cells
in the acute phase
semi-quantitative IgM 96 x 01
EI 217a-9601-2 M
EUROLINE positive control serum: IgG, human, 50x concentrated
for Borrelia
IgG 05 x 07
CL 2131-0507 G
EUROLINE positive control serum: IgM, human, 50x concentrated
for Borrelia
IgM 05 x 07
CL 2131-0507 M
EUROLINE Anti-Borrelia EUROLINE-RN-AT-adv (IgM)
(OspC-adv Bsp, OspC-adv Bg, OspC-adv
Bb, OspC-adv Ba, p39, VlsE Bb separately)
EUROLINE IgM
IgM
IgM
240 x 01
32 x 01
50 x 01
DN 2131-24001-2 M
DN 2131-3201-2 M
DN 2131-5001-2 M
WESTERNBLOT antibodies against Borrelia afzelii
IgG positive control
(Westernblot/EUROLINE-WB)
IgG 50 x 05
CW 2131-5005 G
WESTERNBLOT antibodies against Borrelia afzelii
IgM positive control
(Westernblot/EUROLINE-WB)
IgM 50 x 05
CW 2131-5005 M
WESTERNBLOT antibodies against Borrelia burgdorferi
IgG positive control
IgG 50 x 05
CW 2132-5005 G
WESTERNBLOT antibodies against Borrelia burgdorferi
IgM positive control
IgM 50 x 05
CW 2132-5005 M
WESTERNBLOT antibodies against Borrelia garinii
IgG positive control
IgG 50 x 05
CW 2134-5005 G
WESTERNBLOT antibodies against Borrelia garinii
IgM positive control
IgM 50 x 05
CW 2134-5005 M
WESTERNBLOT Anti-Borrelia EUROLINE-WB (IgG) Westernblot whole antigen, SDS extract of
Borrelia afzelii plus VlsE
IgG
IgG
IgG
IgG
16 x 01
240 x 01
30 x 01
48 x 01
DY 2131-1601-1 G
DY 2131-24001-1 G
DY 2131-3001-1 G
DY 2131-4801-1 G
WESTERNBLOT Anti-Borrelia EUROLINE-WB (IgM) Westernblot whole antigen, SDS extract of
Borrelia afzelii plus VlsE
IgM
IgM
IgM
IgM
16 x 01
240 x 01
30 x 01
48 x 01
DY 2131-1601-1 M
DY 2131-24001-1 M
DY 2131-3001-1 M
DY 2131-4801-1 M
WESTERNBLOT Anti-Borrelia afzelii-WESTERNBLOT (IgG) Westernblot whole antigen, SDS extract of
Borrelia afzelii
IgG
IgG
240 x 01
30 x 01
DY 2131-24001 G
DY 2131-3001 G
WESTERNBLOT Anti-Borrelia afzelii-WESTERNBLOT (IgM) Westernblot whole antigen, SDS extract of
Borrelia afzelii
IgM
IgM
240 x 01
30 x 01
DY 2131-24001 M
DY 2131-3001 M
WESTERNBLOT Anti-Borrelia burgdorferi-WESTERNBLOT (IgG) Westernblot whole antigen, SDS extract of
Borrelia burgdorferi sensu stricto
IgG 30 x 01
DY 2132-3001 G
WESTERNBLOT Anti-Borrelia burgdorferi-WESTERNBLOT (IgM) Westernblot whole antigen, SDS extract of
Borrelia burgdorferi sensu stricto
IgM 30 x 01
DY 2132-3001 M
WESTERNBLOT Anti-Borrelia garinii-WESTERNBLOT (IgG) Westernblot whole antigen, SDS extract
of Borrelia garinii
IgG 30 x 01
DY 2134-3001 G
WESTERNBLOT Anti-Borrelia garinii-WESTERNBLOT (IgM) Westernblot whole antigen, SDS extract of
Borrelia garinii
IgM 30 x 01
DY 2134-3001 M
ChLIA IDS Borrelia IgG antigenic coated magnetic particles Borrelia burgdorferi VlsE antigen semi-quantitative
100 x 01
IS-ID62011
ChLIA IDS Borrelia IgM antigenic coated magnetic particles B. afzelii, B. burgdorferi, B. garinii, B. spielmani OspC and B. burgdorferi VlsE antigen semi-quantitative
100 x 01
IS-ID62021
ChLIA IDS Borrelia Control Set 3 x 1.5 ml Control 1/2 human serum 2 concentrations
IS-ID62301
ChLIA Anti-Borrelia ChLIA (IgG) Antigen-coated magnetic particles recombinant VlsE,
recombinant DbpA
quantitative IgG 100 x 1
LI 2132-10010 G
ChLIA Anti-Borrelia ChLIA (IgM) Antigen-coated magnetic particles recombinant OspC quantitative IgM 100 x 1
LI 2132-10010 M
ChLIA Control set Anti-Borrelia ChLIA (IgG) 2 x 0.5 ml control 1/2 IgG 02 x 02
LR 2132-20210 G
ChLIA Control set Anti-Borrelia ChLIA (IgM) 2 x 0.5 ml control 1/2 IgM 02 x 02
LR 2132-20210 M
MICROBLOT EUROMicroblot Anti Borrelia (IgG) IgG 96 x 01
KN 2131-9601 G
MICROBLOT EUROMicroblot Anti Borrelia (IgM) IgM 96 x 01
KN 2131-9601 M
* For research use only, not for in vitro diagnostic use in the sense of EU directive 98/79/EC.
1 Product manufactured by third party. Please contact your local Euroimmun representative for more information.